These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15719095)

  • 21. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
    Heidinger M; Kolb H; Krell HW; Jochum M; Ries C
    Biol Chem; 2006 Jan; 387(1):69-78. PubMed ID: 16497166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site.
    Yamamoto D; Takai S; Miyazaki M
    Biochem Biophys Res Commun; 2007 Mar; 354(4):981-4. PubMed ID: 17275782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.
    Rosenblum G; Van den Steen PE; Cohen SR; Grossmann JG; Frenkel J; Sertchook R; Slack N; Strange RW; Opdenakker G; Sagi I
    Structure; 2007 Oct; 15(10):1227-36. PubMed ID: 17937912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of progesterone on the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in human ectopic endometrial stromal cells].
    Chen JL; Lin QH; Fang XL; Tao GS; Huang FY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):307-11. PubMed ID: 16045020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
    O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
    Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
    Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
    Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
    Suminoe A; Matsuzaki A; Hattori H; Koga Y; Ishii E; Hara T
    Leuk Res; 2007 Oct; 31(10):1437-40. PubMed ID: 17350093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octaarginine-liposomes as an effective vaccine carrier for mature dendritic cells.
    Park K
    J Control Release; 2009 May; 136(1):1. PubMed ID: 19351550
    [No Abstract]   [Full Text] [Related]  

  • 35. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of photocleavable liposomes and the mechanism of their content release.
    Chandra B; Subramaniam R; Mallik S; Srivastava DK
    Org Biomol Chem; 2006 May; 4(9):1730-40. PubMed ID: 16633565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloride ion efflux from liposomes is controlled by sidechains in a channel-forming heptapeptide.
    You L; Ferdani R; Gokel GW
    Chem Commun (Camb); 2006 Feb; (6):603-5. PubMed ID: 16446823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes].
    Lu D; Wang ZX; Wang XL; Gu XW; Wang YX; Fu D
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):20-4. PubMed ID: 16635322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
    Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.